Isolated limb infusion as a model to test new agents to treat metastatic melanoma

Michael E. Lidsky, Paul J. Speicher, Betty Jiang, Masahito Tsutsui, Douglas S. Tyler

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The limb model of in-transit disease can expand our understanding of treating melanoma because of the ease of obtaining tissue biopsies for correlative studies and the availability of preclinical animal models that allow validation of novel therapeutic strategies. This review will focus on regional therapy for in-transit melanoma as a platform to investigate novel therapeutic approaches to improve regional disease control, and help us develop insights to more rationally design systemic therapy trials. J. Surg. Oncol. 2014 109:357-365.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalJournal of Surgical Oncology
Issue number4
StatePublished - Mar 2014
Externally publishedYes


  • in-transit
  • isolated limb infusion
  • melanoma

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Isolated limb infusion as a model to test new agents to treat metastatic melanoma'. Together they form a unique fingerprint.

Cite this